Jacques, C.; Marchesi, I.; Fiorentino, F.P.; Marchand, F.; Chatelais, M.; Floris, I.
Active Substances from the Micro-Immunotherapy Medicine 2LC1® Show In Vitro Anti-Cancer Properties in Colon, Prostate, and Breast Cancer Models and Immune-Enhancing Capabilities in Human Macrophages. Int. J. Mol. Sci. 2025, 26, 4300.
https://doi.org/10.3390/ijms26094300
AMA Style
Jacques C, Marchesi I, Fiorentino FP, Marchand F, Chatelais M, Floris I.
Active Substances from the Micro-Immunotherapy Medicine 2LC1® Show In Vitro Anti-Cancer Properties in Colon, Prostate, and Breast Cancer Models and Immune-Enhancing Capabilities in Human Macrophages. International Journal of Molecular Sciences. 2025; 26(9):4300.
https://doi.org/10.3390/ijms26094300
Chicago/Turabian Style
Jacques, Camille, Irene Marchesi, Francesco Paolo Fiorentino, Flora Marchand, Mathias Chatelais, and Ilaria Floris.
2025. "Active Substances from the Micro-Immunotherapy Medicine 2LC1® Show In Vitro Anti-Cancer Properties in Colon, Prostate, and Breast Cancer Models and Immune-Enhancing Capabilities in Human Macrophages" International Journal of Molecular Sciences 26, no. 9: 4300.
https://doi.org/10.3390/ijms26094300
APA Style
Jacques, C., Marchesi, I., Fiorentino, F. P., Marchand, F., Chatelais, M., & Floris, I.
(2025). Active Substances from the Micro-Immunotherapy Medicine 2LC1® Show In Vitro Anti-Cancer Properties in Colon, Prostate, and Breast Cancer Models and Immune-Enhancing Capabilities in Human Macrophages. International Journal of Molecular Sciences, 26(9), 4300.
https://doi.org/10.3390/ijms26094300
